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INTRODUCTION: The six-minute walk test (6WT) has been proposed to be a submaximal test, but could actually demand a high 
level of exercise intensity from the patient, expressed by a respiratory quotient >1.0, following the guideline recommendations. 
Standardizing the 6WT using the Borg scale was proposed to make sure that all patients undergo a submaximal walking test. 
PURPOSE: To test the reproducibility of the six-minute treadmill cardiopulmonary walk test (6CWT) using the Borg scale and 
to make sure that all patients undergo a submaximal test. 
METHODS: Twenty-three male heart failure patients (50±9 years) were included; these patients had both ischemic (5) and non-
ischemic (18) heart failure with a left ventricle ejection fraction of 23±7%, were diagnosed as functional class NYHA II-III and 
were undergoing optimized drug therapy. Patients were guided to walk at a pace between “relatively easy and slightly tiring” (11 
and 13 on Borg scale). The 6CWT using the Borg scale was performed two times on a treadmill with zero inclination and patient 
control of speed with an interval of 24 hours. During the sixth minute, we analyzed ventilation (VE, L/min), respiratory quotient, 
Oxygen consumption (VO
2
, ml/kg/min), VE/VCO
2
 slope, heart rate (HR, bpm), systolic blood pressure (SBP, mmHg), diastolic 
(DBP, mmHg) blood pressure and distance. 
RESULTS: The intraclass correlation coefficients at the sixth minute were: HR (r
i
=0.96, p<0.0001), VE (r
i
=0.84, p<0.0001), SBP 
(r
i
=0.72, p=0.001), distance (r
i
=0.88, p<0.0001), VO
2
(r
i
=0.92, p<0.0001), SlopeVE/VCO
2
 (r
i
=0.86, p<0.0001) and RQ<1 (r
i
=0.6,
p=0.004).
CONCLUSION: Using the 6CWT with the Borg scale was reproducible, and it seems to be an appropriate method to evaluate the 
functional capacity of heart failure patients while making sure that they undergo a submaximal walking test.
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BACKGROUND
Heart failure can be considered as the last stage of heart 
diseases and as a significant cause of mortality and mor-
bidity throughout the world.1 A limited effort tolerance is 
frequently both the first and most important clinical char-
acteristic of heart failure, reflecting the reduction in cardiac 
function and the alteration in reflex, metabolic, vascular and 
muscular function.1,2
The maximal exercise cardiopulmonary test is performed 
to evaluate the functional capacity, therapeutic response and 
prognosis in heart failure patients.3,4 The six-minute walk test 
is proposed to be a submaximal exam that could reproduce a 
patient’s daily physical activities and evaluate the prognosis 
of heart failure patients.5 However, if the original version is 
followed, the six-minute walk test could demand a higher ex-
ercise intensity than that demanded during the patient’s daily 
activities,6-8 as expressed by a respiratory quotient (RQ)>1.0.6
The Centers for Disease Control and Prevention recognize 
submaximal activities as 3 to 6 METs, which corresponds to 
a moderate intensity for most young to middle-aged adults.6
To make sure that all patients undergo a submaximal test, a 
careful standardization was proposed using the Borg scale 
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(submaximal is defined as between relatively easy and slight-
ly tiring, which is between 11 and 13 on the scale).6 The 
reproducibility of this new standardization is unknown.
The aim of this study was to test the reproducibility of the 
six-minute treadmill cardiopulmonary walking test (6CWT) 
using the Borg scale in patients with stable heart failure and to 
make sure that all patients undergo a submaximal test.
MATERIALS AND METHODS
Twenty-three male heart failure patients (50±9 years) 
were included in the study. Baseline characteristics are 
listed in table 1. Patients with any of the following were 
excluded from the study: non-optimized drug therapy, atrial 
fibrillation, cachexia, interrupted walk test prior to the sixth 
minute and noncardiovascular functional limitations, such 
as osteoarthritis and chronic obstructive pulmonary disease. 
Female patients were not included in this study due to the re-
duced number of females available during the study period.
All patients were in stable clinical condition, without 
changes in medication for three months. Patients performed 
both tests at least two hours after a light meal. The 6CWT 
was conducted by two randomized physical therapists on two 
consecutive days.
All patients underwent the exercise test on a programma-
ble treadmill (Series 2000; Marquette Electronics; Milwau-
kee, WI, USA) in a temperature-controlled room (21-23 °C) 
with continuous electrocardiography monitoring (Max 1; 
Marquette Electronics; Milwaukee, WI, USA), blood pres-
sure monitoring (auscultation method) and ventilation and 
gas exchange monitoring (computerized system, Vmax 229 
model, SensorMedics, Yorba Linda, CA, USA).
The 6CWT using the Borg scale was performed on a 
treadmill with zero inclination and patient-controlled speed7.
All patients were advised to keep walking during the test at a 
pace between “relatively easy and slightly tiring” (between 
11 and 13 on the Borg scale). The distance walked was 
recorded by the treadmill microprocessor. Encouragement 
was standardized with phrases like “if you can walk faster, 
increase the speed”, “you are doing very well” and “if it 
is tiring, you can reduce the speed”. Blood pressure was 
measured at rest and at the sixth minute. The electrocardi-
ography, ventilatory, hemodynamic and gas exchange vari-
ables were continuously evaluated during the test but only 
collected at the sixth minute. The protocol was approved 
by the Ethical Committee of Heart Institute of São Paulo’s 
Medical School. All patients provided informed consent 
before participation.
STATISTICAL ANALYSIS
Data were analyzed using SPSS statistical software for 
Windows version 11.5 (SPSS Inc., Chicago, IL, USA). The 
descriptive analysis was presented as mean and standard 
deviation. Intraclass Correlation Coefficients (r
i
), with a 95% 
confidence interval, were calculated using analysis of variance 
(ANOVA)24 for the following variables: ventilation (VE, L/
min), RQ, oxygen consumption (VO
2
, ml/kg/min), VE/VCO2 
slope, heart rate (HR, bpm), systolic blood pressure (SBP, 
mmHg), diastolic (DBP, mmHg) blood pressure and distance 
(miles). p<0.05 was considered significant. Bland-Altman 
plots with 95% limits of agreements were also derived.
RESULTS
All patients were well-adapted to the six-minute walk 
test using the Borg scale and completed the protocol with-
out interference. Results are listed in table 2 and the linear 
regression is presented in figure 1. The distance was highly 
reproducible between the two tests (0.20o0.03 vs 0.20o0.04 
miles or 321 meters; r
i
=0.88, p<0.0001), as was VO
2
(11o2
vs 11o2 ml/kg/min; r
i
=0.92, p<0.0001). Only DBP did not 
show reproducibility (r
i
=0.33, p=ns). The Bland-Altman 
plots for the six-minute walk test using the Borg scale are 
shown in figures 2 and 3.
Table 1 - Characteristics of patients
Characteristics Number of 
Patients (%)
Pathogenesis
Ischemic 5 (21.7%)
Chagasic 4 (17.3%)
Idiopatic dilated cardiomyopathy 7 (30.4%)
Hypertensive 5 (21.7%)
Valvar 2 (8.6%)
Left ventricular ejection fraction (echo), % 23o7
Left ventricular end-diastolic diameter (echo), mm 72o16
NYHA functional class
II 19 (82.6%)
III 4 (17.3%)
Current medications
Digoxin 18 (78.2%)
Diuretics 21 (91.3%)
ACE inhibitor 19 (82.6%)
AT1 Blocker 2 (8.6%)
Spironolactone 13 (56.5%)
B-blocker 14 (60.8%)
Amiodarone 4 (17.3%)
Nitrate 2 (8.6%)
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DISCUSSION
In this study, we tested the reproducibility of the 6CWT 
using the Borg scale proposed by Guimarães et al., 2002.6 The 
six-minute walk test’s guideline does not recommend a tread-
mill walk test because patients are unable to pace themselves.8
In our study, all patients were well-adapted to the method and 
were able to pace themselves. Studies with chronic obstruc-
tive pulmonary disease showed that the distance walked on a 
treadmill was less than the distance in a corridor.9,10 Follow-
ing the [current?] guidelines, the patient’s instruction for the 
six-minute walk test was: “walk as far as you can.”11 A previ-
ous study demonstrated that the six-minute walk test could 
demand a higher exercise intensity than that achieved while 
performing daily activities (RQ>1.0) when the guideline’s 
standard recommendations are followed.6 The Borg scale is a 
valid measure of relative intensity, showing good correlation 
with heart and exercise rate.11
Some studies require the patient to become familiar with 
the six-minute walk test.12-14 A learning effect of 6% was 
reported in a cardiac rehabilitation population that completed 
the test on non-consecutive days.12 In our study, patients did 
not undergo familiarization, and it was not important for the 
reproducibility of the principal variables. There is no data 
available regarding the reproducibility of the six-minute-
walk test using the Borg scale.
In our study, heart rate, systolic blood pressure and 
ventilation were reproducible. It is known that heart rate 
correlates with exercise intensity14, and we expected this 
reproducibility because exercise intensity has been standard-
ized by the Borg scale. The reproducibility of the maximum 
cardiopulmonary test was studied previously24 and showed 
Table 2 - Intraclass Correlations Coefficients (ri) for six-minute cardiopulmonary walking test-related parameters
Parameter Test 1 Test 2 r
i
p (ANOVA)
HR (bpm) 96o21 90o19 0.96 <0.0001
VE (l/min) 25o05 25o05 0.84 <0.0001
VO
2
 (ml/kg/min) 11o2 11o2 0.92 <0.0001
SBP (mmHg) 125o20 119o20 0.72 0.001
DBP (mmHg) 70o12 69o12 0.33 Ns
Distance (miles) 0.20o0.03 0.20o0.04 0.88 <0.0001
Slope VE/VCO
2
32o7 32o6 0.86 <0.0001
RQ 0.9±0.03 0.87±0.04 0.6 0.004
*Values are mean and SD. HR= heart rate; SBP= systolic blood pressure; DBP= diastolic blood pressure; VO
2
= oxygen consumption; RQ=respiratory 
quotient.
Figure 1 - Regression linear between test-1 and test-2 for VO2 (A) and Distance (B)
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good reproducibility for both heart rate and ventilation at an 
anaerobic threshold and during a peak exercise test. In the 
present study, only diastolic blood pressure did not show re-
producibility. No data are available about the reproducibility 
of ventilation, heart rate, systolic or diastolic blood pressure 
during the six-minute walking test.
All of our patients showed good RQ reproducibility, 
which remained less than 1.0 during the entire six-minute 
cardiopulmonary walking test. An RQ above 1.0 character-
izes a tester near their maximum effort.13 In this study, our 
methodology assured a submaximal walking test. There 
are no available studies with six-minute cardiopulmonary 
walking tests showing RQ values. The American Thoracic 
Society Guidelines for the six-minute walk test11 recommend 
that patients should walk “as far as possible for 6 minutes” 
and recognize that patients “will probably get out of breath 
or become exhausted”, suggesting that a maximum exercise 
test can occur.
In our study, the VE/VCO
2
 slope showed good repro-
ducibility. Previous studies showed that the VE/VCO
2
 slope 
predicts mortality and morbidity in heart failure patients 
who underwent a maximal cardiopulmonary test.14-16 In the 
6CWT, this variable is correlated with distance and also 
predicts mortality and morbidity in patients with primary 
pulmonary hypertension.14 There is no data available about 
the VE/VCO
2
 slope during the six-minute walk test in heart 
failure patients. Reproducibility of the VE/VCO
2
 slope at an 
anaerobic threshold was investigated in a maximal cardiopul-
monary test and showed a good correlation.15
In our study, VO
2
at the sixth minute showed good repro-
ducibility. This result could be important in meta-analysis 
studies because VO
2
 could be accessed without the influence 
of a physical therapist’s encouragement. Peak oxygen con-
sumption is the standard measurement to evaluate exercise 
capacity and is a powerful predictor of mortality in heart 
failure patients.16-18 The six-minute walk test distance in heart 
failure patients correlated with peak O
2
 consumption and 
could predict peak VO
2
 in advanced heart failure patients.30
The Centers for Disease Control and Prevention recognize 
submaximal activities as 3 to 6 METs, which corresponds to 
moderate intensity for most young to middle-age adults.9 In 
our study, the METs average was less than 3.2. Once again, 
our methodology assured a submaximal walking test. The 
reproducibility of the peak VO
2
at anaerobic threshold and 
Figure 2 - Bland & Altman plots between test-1 and test-2 for VO2, Heart Rate (HR), Systolic (SBP) and Diastolic Blood Pressure (DBP)
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Figure 3 - Bland & Altman plots between test-1 and test-2 for slope VE/VCO2, distance and ventilation
during a maximum cardiopulmonary test was investigated, 
and a good correlation was found.24
Walking distance showed good reproducibility in our 
study. This could be important to evaluate the walking 
distance in meta-analysis studies without the influence of a 
physical therapist’s encouragement. Previous studies showed 
that the distance walked during the six-minute walk test 
strongly predicts mortality and morbidity.16,16,17 A walked 
distance of less than 300 meters predicts death or hospital 
admission for inotropic or mechanical bridging to transplan-
tation in a period of six months.18 Excess encouragement 
significantly increased the walked distance19, which is why 
we standardized it with the Borg scale. A study evaluated 
heart failure patients (n=233) three times: two times within 
an interval of 30 minutes and another one day after. The tests 
were performed in a hospital corridor (34 meters of length) 
with previous familiarization, and all of the exams were very 
reproducible.15 Another study evaluated the distance covered 
during the six-minute walk test one year after the original 
test in 1,077 heart failure patients using a 15-meter corridor. 
The distance correlated with self-perceived symptom chang-
es, as evaluated by a questionnaire. The authors concluded 
that the distance is sensitive to changes in self-perceived 
symptoms of heart failure; when the self-perception does not 
change, the distance walked is reproducible.16
LIMITATIONS
This study was limited by both the number and gender of 
available patients, although our data showed reproducibility 
of the most important variables for the 6CWT. Prognosis 
based on distance should have a different cutoff point than 
the previously mentioned 300-m cutoff point. More studies 
with a greater number of heart failure patients (including 
females) are necessary for a better comprehension of the 
6CWT using the Borg scale.
CONCLUSION
The 6CWT using the Borg scale in heart failure patients 
was reproducible and assured a submaximal walking test. 
These results suggest that our methodology may be ap-
propriate for evaluating functional capacity in heart failure 
patients. However, more studies are necessary for better 
comprehension.
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